Why India Must Adopt HPV DNA Testing for Cervical Cancer

India must urgently reform its cervical cancer screening strategies to save millions of women. According to Padma Shri Dr. Neerja Bhatla, the country should prioritize HPV DNA testing over traditional methods. While vaccination protects future generations, active molecular screening remains crucial for protecting the current adult population at risk.

The Superiority of HPV DNA Testing

Currently, India relies heavily on Visual Inspection with Acetic Acid (VIA). However, this method has lower accuracy and higher false-positive rates. In contrast, the World Health Organization strongly recommends HPV DNA testing due to its exceptional sensitivity. This molecular method identifies high-risk viral strains before precancerous lesions develop. Therefore, clinical guidelines should shift to molecular diagnostics as the primary screening tool.

Balancing Sensitivity and Specificity in Indian Healthcare

Public health strategies often emphasize sensitivity to detect every possible case. Nonetheless, Dr. Bhatla emphasizes that specificity is equally vital in resource-constrained environments. False-positive results trigger unnecessary diagnostic referrals and biopsies. Consequently, these avoidable procedures overload tertiary care hospitals and create immense patient anxiety. Fortunately, modern targeted assays improve specificity while maintaining high clinical sensitivity for those specializing in gynaecology.

Leveraging Indigenous Point-of-Care Innovations

Patient compliance determines the ultimate success of screening initiatives. For instance, many rural women struggle with repeated clinic visits due to travel costs and childcare responsibilities. Therefore, India must deploy point-of-care molecular platforms that deliver rapid results within an hour. The recently validated Truenat HPV-HR Plus assay represents a major milestone in this transition. This platform provides highly accurate, decentralized testing without requiring complex laboratory infrastructure. Additionally, same-day results ensure immediate counseling and minimize loss to follow-up.

Three Key Strategic Reforms

To eliminate cervical cancer, policymakers should implement three major interventions. First, they must transition from opportunistic to organized, population-based screening. Second, they should establish molecular diagnostics as the national primary standard. Third, they must strengthen overall healthcare governance and workforce training. Although implementing these steps requires substantial funding, it guarantees long-term clinical sustainability.

Frequently Asked Questions

Q1: Why is HPV DNA testing preferred over Visual Inspection with Acetic Acid (VIA)?

HPV DNA testing has much higher clinical sensitivity and accuracy compared to VIA, which has a higher rate of false-positive results and lower diagnostic reliability.

Q2: How do rapid, point-of-care tests like Truenat HPV-HR Plus improve patient compliance?

These tests deliver results in less than an hour, enabling same-day counseling and clinical decision-making during a single visit, thereby preventing loss to follow-up.

Q3: Why can’t HPV vaccination alone eliminate cervical cancer in the current generation?

Vaccination primarily protects younger generations who have not yet been exposed to the virus, whereas millions of adult women are already at risk and require routine screening through advanced clinical practices.

References

1. India Must Shift to HPV DNA-Based Screening to Eliminate Cervical Cancer, SaysDr Neerja Bhatla – ETHealthworld
2. India successfully validates the first indigenous HPV test for cervical cancer screening – BioSpectrum India
3. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of human papillomavirus (HPV) DNA genotyping – World Health Organization

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.